VOR BIOPHARMA INC (VOR) Stock Overview
USA - NASDAQ:VOR - US9290331084 - Common Stock
VOR Key Statistics, Chart & Performance
The current stock price of VOR is 29 USD. In the past month the price increased by 6.46%. In the past year, price increased by 110.15%.
VOR Latest News, Press Relases and Analysis
VOR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.68 | 405.55B | ||
| AMGN | AMGEN INC | 13.7 | 160.87B | ||
| GILD | GILEAD SCIENCES INC | 15.87 | 152.38B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.61 | 106.87B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 63.14B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.67 | 61.27B | ||
| ARGX | ARGENX SE - ADR | 91.6 | 51.94B | ||
| INSM | INSMED INC | N/A | 35.04B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.11 | 34.76B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.28B | ||
| NTRA | NATERA INC | N/A | 24.94B | ||
| BIIB | BIOGEN INC | 8.93 | 20.97B |
Related stock screener links
About VOR
Company Profile
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. The company is headquartered in Boston, Massachusetts and currently employs 159 full-time employees. The company went IPO on 2021-02-05. The firm is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.
Company Info
VOR BIOPHARMA INC
500 Boylston Street, Suite 1350
Boston MASSACHUSETTS US
Employees: 154
Phone: 16176556580
VOR BIOPHARMA INC / VOR FAQ
What is the stock price of VOR BIOPHARMA INC today?
The current stock price of VOR is 29 USD. The price decreased by -0.21% in the last trading session.
What is the ticker symbol for VOR BIOPHARMA INC stock?
The exchange symbol of VOR BIOPHARMA INC is VOR and it is listed on the Nasdaq exchange.
On which exchange is VOR stock listed?
VOR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VOR BIOPHARMA INC stock?
9 analysts have analysed VOR and the average price target is 36.47 USD. This implies a price increase of 25.74% is expected in the next year compared to the current price of 29. Check the VOR BIOPHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VOR BIOPHARMA INC worth?
VOR BIOPHARMA INC (VOR) has a market capitalization of 198.36M USD. This makes VOR a Micro Cap stock.
How many employees does VOR BIOPHARMA INC have?
VOR BIOPHARMA INC (VOR) currently has 154 employees.
What are the support and resistance levels for VOR BIOPHARMA INC (VOR) stock?
VOR BIOPHARMA INC (VOR) has a support level at 27.24 and a resistance level at 47.71. Check the full technical report for a detailed analysis of VOR support and resistance levels.
Should I buy VOR BIOPHARMA INC (VOR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VOR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VOR, evaluating the profitability, health, valuation and growth aspects
- VOR BIOPHARMA INC (VOR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VOR BIOPHARMA INC (VOR) Sales and EPS estimates to see what analysts future expectations are.
- VOR BIOPHARMA INC (VOR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VOR BIOPHARMA INC (VOR) Insider and Institutional Ownership to learn about the owners and their transactions.
- VOR BIOPHARMA INC (VOR) Stock Chart to make your own analysis
- VOR BIOPHARMA INC (VOR) Latest news and press-releases to stay up to date.
Does VOR BIOPHARMA INC (VOR) stock pay dividends?
VOR does not pay a dividend.
When does VOR BIOPHARMA INC (VOR) report earnings?
VOR BIOPHARMA INC (VOR) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of VOR BIOPHARMA INC (VOR)?
VOR BIOPHARMA INC (VOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-49.84).
VOR Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to VOR. When comparing the yearly performance of all stocks, VOR is one of the better performing stocks in the market, outperforming 89.74% of all stocks.
VOR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VOR. Both the profitability and financial health of VOR have multiple concerns.
VOR Financial Highlights
Over the last trailing twelve months VOR reported a non-GAAP Earnings per Share(EPS) of -49.84. The EPS decreased by -2764.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -810.45% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VOR Forecast & Estimates
9 analysts have analysed VOR and the average price target is 36.47 USD. This implies a price increase of 25.74% is expected in the next year compared to the current price of 29.